Climate Change Data

ImmuneOnco Biopharmaceuticals (Shanghai) Inc.

Climate Impact & Sustainability Data (2023)

Reporting Period: 2023

Environmental Metrics

Total Carbon Emissions:1639.62 tCO2e/year
Scope 1 Emissions:5.1 tCO2e/year
Scope 2 Emissions:1634.52 tCO2e/year
Scope 3 Emissions:Not disclosed
Renewable Energy Share:Not disclosed
Total Energy Consumption:2342.04 kWh in '000s/year
Water Consumption:4670.00 tonnes/year
Waste Generated:14.48 tonnes/year
Carbon Intensity:Not disclosed

ESG Focus Areas

  • Innovative R&D
  • Quality management and control
  • Intellectual property protection
  • Occupational health and safety
  • Supply chain management
  • Employee training and development
  • Corporate governance
  • Information system management
  • Operational compliance
  • Data privacy protection
  • Emissions management
  • Cooperation and development
  • Employee benefits
  • Energy utilization
  • Anti-corruption
  • Employment compliance, equity, and diversity
  • Public welfare
  • Climate change management

Environmental Achievements

  • Implemented energy-saving measures resulting in maintaining previous energy consumption levels while implementing further energy saving and emission reduction.
  • Wastewater discharge pollutant concentration met the requirements of Pollutant Emission Standards for Biopharmaceutical Industry (DB31/373–2010), and LAS met the tertiary standard of Shanghai’s Comprehensive Wastewater Emission Standards (DB31/199– 2018).

Social Achievements

  • Organized four occupational health trainings with no occupational disease incidents.
  • Maintained an employee turnover rate of 12%.

Governance Achievements

  • Established a “Zero Tolerance” policy to corruption, developing systems including the Anti-fraud Management Policy, the Anti-money Laundering Management Policy, and the Misconduct Reporting and Investigation Management Policy.
  • Conducted compliance training sessions on trade secret protection, intellectual property-related risk prevention in procurement, and other topics.

Climate Goals & Targets

Long-term Goals:
  • Not disclosed
Medium-term Goals:
  • Not disclosed
Short-term Goals:
  • Not disclosed

Environmental Challenges

  • Not disclosed
Mitigation Strategies
  • Not disclosed

Supply Chain Management

Supplier Audits: On-site audits of new culture media suppliers in 2023

Responsible Procurement
  • Procurement Management Regulations, Office Supplies Procurement Management Measures, and Services Procurement Management Measures

Climate-Related Risks & Opportunities

Physical Risks
  • Not disclosed
Transition Risks
  • Not disclosed
Opportunities
  • Not disclosed

Reporting Standards

Frameworks Used: Appendix C2, the Environmental, Social and Governance Reporting Guide to the Rules Governing the Listing of Securities on the Stock Exchange of Hong Kong Limited

Certifications: Null

Third-party Assurance: Not disclosed

UN Sustainable Development Goals

  • Not disclosed

Not disclosed

Sustainable Products & Innovation

  • Not disclosed

Awards & Recognition

  • The 2nd Biotech Innovation 50 Companies List
  • The 7th Future Healthcare 100 Main List — China Innovative Biomedical List — 7th place in 2023
  • Zhangjiang Life & Health Industry Emerging Company of the Year
  • 2023 Influential Science and Innovation Enterprise of the Year